Literature DB >> 15653318

Structures of cytochrome P450 3A4.

Emily E Scott1, James R Halpert.   

Abstract

Cytochrome P450 3A4 (CYP3A4) catalyzes the initial step in the clearance of many pharmaceuticals and foreign chemicals. The structurally diverse nature of CYP3A4 substrates complicates rational prediction of their metabolism and identification of potential drug interactions. The first molecular structures of human CYP3A4 were recently determined, revealing an active site of sufficient size and topography to accommodate either large ligands or multiple smaller ligands, as suggested by the heterotropic and homotropic cooperativity of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653318     DOI: 10.1016/j.tibs.2004.11.004

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  27 in total

1.  An in vivo assay for elucidating the importance of cytochromes P450 for the ability of a wild mammalian herbivore (Neotoma lepida) to consume toxic plants.

Authors:  Michele M Skopec; Jael R Malenke; James R Halpert; M Denise Dearing
Journal:  Physiol Biochem Zool       Date:  2013-08-14       Impact factor: 2.247

2.  A malleable catalyst dominates the metabolism of drugs.

Authors:  F Peter Guengerich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

3.  A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system.

Authors:  Su-Jun Lee; Ilse P van der Heiden; Joyce A Goldstein; Ron H N van Schaik
Journal:  Drug Metab Dispos       Date:  2006-10-11       Impact factor: 3.922

Review 4.  Substrate binding to cytochromes P450.

Authors:  Emre M Isin; F Peter Guengerich
Journal:  Anal Bioanal Chem       Date:  2008-07-13       Impact factor: 4.142

5.  Exploration of 3,6-dihydroimidazo(4,5-d)pyrrolo(2,3-b)pyridin-2(1H)-one derivatives as JAK inhibitors using various in silico techniques.

Authors:  Radhakrishnan S Jisha; Lilly Aswathy; Vijay H Masand; Jayant M Gajbhiye; Indira G Shibi
Journal:  In Silico Pharmacol       Date:  2017-10-12

6.  Defining CYP3A4 structural responses to substrate binding. Raman spectroscopic studies of a nanodisc-incorporated mammalian cytochrome P450.

Authors:  Piotr J Mak; Ilia G Denisov; Yelena V Grinkova; Stephen G Sligar; James R Kincaid
Journal:  J Am Chem Soc       Date:  2011-01-05       Impact factor: 15.419

7.  Nitric oxide blocks cellular heme insertion into a broad range of heme proteins.

Authors:  Syed Mohsin Waheed; Arnab Ghosh; Ritu Chakravarti; Ashis Biswas; Mohammad Mahfuzul Haque; Koustubh Panda; Dennis J Stuehr
Journal:  Free Radic Biol Med       Date:  2010-03-06       Impact factor: 7.376

Review 8.  The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis.

Authors:  Jiezhong Chen; Kong-Nan Zhao; Chen Chen
Journal:  Ann Transl Med       Date:  2014-01

9.  Structural and mechanistic insights into the interaction of cytochrome P4503A4 with bromoergocryptine, a type I ligand.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

10.  Unusual regioselectivity and active site topology of human cytochrome P450 2J2.

Authors:  Pierre Lafite; François André; Darryl C Zeldin; Patrick M Dansette; Daniel Mansuy
Journal:  Biochemistry       Date:  2007-08-17       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.